Drugs firm GSK eyes India acquisitions: chief executive
Monday, October 3, 2011 - 07:00
in Mathematics & Economics
British drugmaker GlaxoSmithKline is in the market to buy assets in India at a total cost of up to $2.0 billion (1.5 billion euros), its chief executive said in an interview published on Monday.